| Literature DB >> 19712708 |
Jennifer A Jacobsen1, Jody L Major Jourden, Melissa T Miller, Seth M Cohen.
Abstract
This short review highlights some recent advances in matrix metalloproteinase inhibitor (MMPi) design and development. Three distinct approaches to improved MMP inhibition are discussed: (1) the identification and investigation of novel zinc-binding groups (ZBGs), (2) the study of non-zinc-binding MMPi, and (3) mechanism-based MMPi that form covalent adducts with the protein. Each of these strategies is discussed and their respective advantages and remaining challenges are highlighted. The studies discussed here bode well for the development of ever more selective, potent, and well-tolerated MMPi for treating several important disease pathologies. Copyright 2009 Elsevier B.V. All rights reserved.Mesh:
Substances:
Year: 2009 PMID: 19712708 DOI: 10.1016/j.bbamcr.2009.08.006
Source DB: PubMed Journal: Biochim Biophys Acta ISSN: 0006-3002